|
所在平台: Coursera |
课程主页: https://www.coursera.org/learn/opioid
课程评论：没有评论
课程名称：影响阿片危机：非处方提供者的预防、教育和实践 课程概述：本课程旨在赋能非处方提供者，帮助他们通过提升知识和工具，直接影响美国当前的阿片危机。课程将介绍阿片流行病，并提供基于证据的预防、干预、教育或政策策略的信息和研究。该开放学习课程主要面向非处方的医疗、行为健康、牙科和社会服务专业人员，以及相关领域的研究生。其他如教育工作者和医生等个体也将从中受益。成功完成课程内容后可以获得执业持续教育（CE）学分。 学习者可以选择任何模块和主题，按照个人的观看顺序线性或非线性完成课程。课程由阿片预防、干预、治疗和政策领域的专家授课，包含讲座、讨论会和访谈、知识检查和测验，以及额外的阅读和活动，帮助学习者深入探索与其工作或实践相关的主题。 本课程由密歇根大学的三个项目开发，包括医疗政策与创新研究所（IHPI）、密歇根阿片处方参与网络（Michigan OPEN）以及由CDC资助的密歇根大学伤害预防中心。 课程包括6个模块，总时长约为15小时。完成此课程可获得15小时的继续医学教育（CME）学分和密歇根社会工作的继续教育学分，以及13小时的密歇根药学继续教育学分。 密歇根大学医学院为本课程指定最多15小时的美国医学会（AMA）持续教育学分（PRA 分类 1学分）。该学院获得继续医学教育认证委员会（ACCME）的认证，提供医疗人员的持续医学教育。 此活动符合美国麻醉学委员会（ABA）重新设计的安眠学认证维护程序（MOCA 2.0）的 CME 组成部分，详情请参阅ABA网站。 课程批准由密歇根药房委员会以及密歇根社会工作继续教育合作委员会，分别提供相关的继续教育学分。 课程大纲如下： - 模块1：阿片危机的流行病学 - 描述：完成此模块后，您将能够解释导致当前阿片危机的因素。 - 模块2：理解疼痛 - 描述：完成此模块后，您将理解疼痛的病理生理及其治疗，包括阿片类药物的作用机制。 - 模块3：滥用和误用的预防 - 描述：完成此模块后，您将了解如何使用各种策略减少阿片类药物的非意图使用和误用。 - 模块4：与患者和公众的合作 - 描述：完成此模块后，您将能够确定可以在临床护理环境和不同人群中促进阿片安全使用的策略和工具。 - 模块5：成瘾治疗和康复 - 描述：完成此模块后，您将能够描述评估和治疗阿片使用障碍（OUD）的最佳实践。 - 模块6：公共政策 - 描述：完成此模块后，您将理解影响阿片流行病的公共政策的不同方面。
Name:Module 1: Epidemiology of the Opioid Crisis
Description:After completing this module, you will be able to explain the factors that contributed to the current opioid crisis.
Name:Module 2: Understanding Pain
Description:After completing this module, you will understand the pathophysiology of pain and its treatment, including what opioids are and how they work.
Name:Module 3: Prevention of Misuse and Abuse
Description:After this module, you will understand how to reduce unintended use and misuse of opioids using various strategies, including prescribing guidelines, surveillance, safe disposal of unused opioids, and intervention messaging.
Name:Module 4: Working with Patients and the Public
Description:After this module, you will be able to identify what strategies and tools you can employ to impact the safe use of opioids across clinical care settings and with a variety of populations.
Name:Module 5: Addiction Treatment and Recovery
Description:After this module, you will be able to describe best practices for assessing and treating opioid use disorder (OUD) and explain the evidence that informs these best practices.
Name:Module 6: Public Policy
Description:After this module, you will understand different aspects of public policy that can impact the opioid epidemic.
This course will empower non-prescribing providers to directly impact the ongoing opioid crisis in the United States through increased knowledge and tools that will transform practice and policies. The course will inform you about the opioid epidemic and provide information and research about evidence-based strategies that are focused on prevention, intervention, education, or policy. This open learning course is designed primarily for non-prescribing healthcare, behavioral health, dental and social services professionals, as well as graduate-level students in these fields. Other individuals may also benefit from this course such as educators and physicians. Continuing Education (CE) for licensure is available upon successful completion of course content. As a learner, you have the ability to select any or all of the modules and topics that interest you. You can complete the course in a linear or non-linear structure according to your preferred viewing order. This course is taught by experts in the field of opioid prevention, intervention, treatment, and policy. Through lectures, panels and interviews, knowledge checks and quizzes, and additional readings and activities, you can explore topics that are most relevant to your work or practice. The course was developed by three University of Michigan programs, including the Institute for Healthcare Policy and Innovation (IHPI), Michigan-Opioid Prescribing Engagement Network (Michigan OPEN) and the CDC-funded University of Michigan Injury Prevention Center. The course consists of 6 “lessons” or modules of varying length, for a total commitment of about 15 hours. This translates to 15 CME and Michigan Social work continuing education credits, and 13 Michigan Pharmacy continuing education credits. The University of Michigan Medical School designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. This course is approved by the Michigan Board of Pharmacy-Approval #539190044. This approval statement is for University of Michigan Institute for Healthcare Policy & Innovation. The Michigan Board of Pharmacy designates this enduring material for a maximum of 13 Continuing Education (CE) Hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. If you would like to earn CME/MOCA credit for participating in this course, please review the information here (https://www.coursera.org/learn/opioid) prior to beginning the activity. This course is approved by the Michigan Social Work Continuing Education Collaborative-Approval #101619-02 for 15 CE hours. The Collaborative is the approving body for the Michigan Board of Social Work.
